Your Partner for Force and Torque Testing Equipment 

Mecmesin, established in 1977, is a leading designer and manufacturer of tensile testers and torque measuring equipment. We offer a full range of precision test systems and instruments that are accurate, reliable and excellent value for money.

Operating under ISO 9001 quality standards, Mecmesin test solutions are used to guarantee the quality of components, materials and finished products, from factory floor through to the R&D laboratory – across all industries in the pharmaceuticals sector.

Backed up by IQ, OQ and PQ document templates to support you in your process validation activities.

Our products enable you to perform checks to ensure:

  • Conformance to standards
  • Optimised design
  • Efficient production
  • Minimum wastage
  • Cost savings
  • Quality

Find out more about our test applications in:

  • Medical devices and components
  • Pharma products and raw materials
  • Packaging systems; CRCs and sterile

scroll down

Medical devices and components testing

Quality and reliability is key in a highly regulated environment, where patient safety is critical.

watch the video

Assembly, removal, operational and disassembly efforts can all be measured to protect and enhance brand reputation:

  • Luer design taper connector torque
  • Syringe glide forces
  • Biopsy injector trigger force
  • Tubing pull-out resistance
  • Needle strength, lancet retention
  • Elastomeric closure puncture

Dispensing mechanisms built into closures or actuation components in dosage devices can be evaluated for security and ease-of-use:

  • Pump and spray compression force
  • Drug delivery dial precision torque

Mecmesin equipment securely clamps these types of components for repeatable testing and our range of loadcells accurately measure the wide range of loads involved.

scroll down

Pharma products and raw materials testing

Our range of OmniTestTM Universal Testing Machines enable the raw materials for packaging, products and components to be accurately characterised in tension and compression, up to 50 kN.

Mecmesin’s VectorProTM software is designed to help facilitate meeting FDA 21 CFR Part 11 requirements, with its database architecture and strict operator permissions features.

Extensometer connectivity and a comprehensive suite of materials testing calculations are included:

  • Ultimate tensile strength (UTS)
  • Stress and strain at break
  • Young’s Modulus
  • Yield and 0.2% offset yield
  • 3 and 4-point flexural modulus

We can test the physical properties of solid and semi-solid samples to evaluate the impact of different ingredient formulations on manufacturing processing parameters and product texture:

  • Aspiration and evacuation syringeability
  • Cream and gel consistency and flow
  • Capsule burst resistance
  • Tablet hardness crush, snap
  • Gel strength

Packaging systems testing including CRCs and sterile

If you manufacture or supply primary, secondary or tertiary (transit) packaging, you need accurate and reliable testing systems to apply stringent industry standard test methods:

  • Openability – peel and tear
  • Sharps container puncture resistance
  • Strength - top-loading and crush
  • Labelling - adhesion and friction

Closure torque testing involves a range of tests for events designed into screw caps and unthreaded stoppers.

This includes the torque to remove or apply the closure and also the measurement of the effort required to overcome safety features:

  • Child-Resistant Closures (CRC)
  • Evaluate push and twist designs
  • Breach tamper-evident features

Mecmesin’s versatile motor-driven testing equipment ensures constant rotational speed control for ultimate repeatability and accuracy. Our fixtures hold flexible specimens without affecting the results.

Contact us for a quote or demo:

Web:  www.Mecmesin.com

Phone: +44 (0) 1403 799979

Email: info@mecmesin.com

Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue